3Wauer R R,Schmalisch G,Bohme B,et al.Randomized double blind trial of Ambroxol for the treatment of respiratory distress[J].Eur J Pediatr,1992,151:357-363.
4Michelow IC, Olsen K, Lozano J, et al. Epidemiology arid clinical characteristics of community acquired pneumonia in hospitalized children. Pediatrics, 2004, 113 (4) :701-707.
5Korppi M, Heinskanen-Kosma T, Kleemola M. Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: serologic results of a prospective, population based study in primary health care. Respirology, 2004, 9(1 ) :109-114.
6Lee KY, Lee HS, Hong JH, et al. Role of prednisolone treatment in severe mycoplasma pneumoniae pneumonia in children. Pediatr Pulminol, 2006, 41 (3):263-268.
7Leong MA, Nachajon R, Ruchelli E, et al. Bronchitis obliterans due to mycoplasma pneumonia. Pediatr Puhnonol, 1997, 23 (5) :375-377.
8Cimolai N. Corticosteroids and complicated Mycoplasma pneumoniae infection. Pediatr Pulmonol, 2006, 41 (10) :1008-1009.
9Waites KB, Talkington DE. Mycoplasma pneumoniae and its role as a human pathogen. Clin M icrobiol Rev,2004, 17 (4) : 697 -728.
10TheSubspecialtyGroupofRespiratoryDiseases TheSocietyofPediatrics ChineseMedicalAssociation(中华医学会儿科学分会呼吸学组).Guide to the diagnosis and treatment of CAP in children(1)[J].中华儿科杂志,2007,45(2):83-90.
